NMAC Announces Covid Safety Protocols for 2022 Biomedical HIV Prevention Summit

NMAC has announced Covid safety protocols for the 2022 Biomedical HIV Prevention Summit in Chicago April 20 and 21:

All conference attendees must be fully vaccinated. Fully vaccinated for the Summit means that registrants have received both shots and a booster if the second shot was received more than six months prior to the conference.  Registrants must upload their vaccine card no later than Friday, April 8 to https://hosted-pages.id.me/health/2022-biomedical-hiv-prevention-summit. If we do not receive vaccine credentials by this date registrants will not be allowed entry to the conference.

Masks are encouraged but not required in the Summit conference space (plenary ballroom, foyers, workshop rooms, exhibit space). For updated information on the City of Chicago’s mask requirements, visit their website – https://www.chicago.gov/city/en/sites/covid-19/home.html.

“We want to make sure that the 2022 Biomedical HIV Prevention Summit is as safe as possible for attendees,” said Paul Kawata, Executive Director of NMAC. “While there is no absolute guarantee, we want to take every reasonable precaution to prevent Covid transmission during the Summit, particularly for our attendees who are living with HIV. These protocols are based on guidelines recommended by the CDC and by requirements posted by the city of Chicago.”